Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Structural basis for understanding oncogenic p53 mutations and designing rescue drugs

2 Oct 2006

Abstract excerpt

The DNA-binding domain of the tumor suppressor p53 is inactivated by mutation in approximately 50% of human cancers. We have solved high-resolution crystal structures of several oncogenic mutants to investigate the structural basis of inactivation and provide information for designing drugs that may rescue inactivated mutants. We found a variety of structural consequences upon mutation: (i) the removal of an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Epigenetics and DNA Methylation
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17015838
DOI: 10.1073/pnas.0607286103

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Structural basis for understanding oncogenic p53 mutations and designing rescue drugsPMID 17015838Read ↗

Structure-function-rescue: the diverse nature of common p53 cancer mutants.Semantic proximity Read ↗

Structural basis of p53 inactivation by cavity-creating cancer mutations and its implications for the development of mutant p53 reactivators.Semantic proximity Read ↗

Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy.Semantic proximity Read ↗

Dynamic perspectives into the mechanisms of mutation-induced p53-DNA binding loss and inactivation using active perturbation theory: Structural and molecular insights toward the design of potent reactivators in cancer therapy.Semantic proximity Read ↗

Targeted rescue of a destabilized mutant of p53 by an in silico screened drug.Semantic proximity Read ↗

Structural biology of the tumor suppressor p53 and cancer-associated mutants.Semantic proximity Read ↗

DARPins as pan-reactivators of temperature-sensitive p53 cancer mutants.Semantic proximity Read ↗

Structural studies of p53 inactivation by DNA-contact mutations and its rescue by suppressor mutations via alternative protein-DNA interactions.Semantic proximity Read ↗

Follow the Mutations: Toward Class-Specific, Small-Molecule Reactivation of p53.Semantic proximity Read ↗

Complete Models of p53 Better Inform the Impact of Hotspot Mutations.Semantic proximity Read ↗

Structural studies on mechanisms to activate mutant p53.Semantic proximity Read ↗

Structural and sequential context of p53: A review of experimental and theoretical evidence.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.